Latanoprost versus timolol as first choice therapy in patients with ocular hypertension. A cost-effectiveness analysis.
about
What the comprehensive economics of blindness and visual impairment can help us understandEffect of hydrophobic and hydrophilic additives on sol-gel transition and release behavior of timolol maleate from polycaprolactone-based hydrogelComparison of resource utilization in the treatment of open-angle glaucoma between two cities in Finland: is more better?
P2860
Latanoprost versus timolol as first choice therapy in patients with ocular hypertension. A cost-effectiveness analysis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Latanoprost versus timolol as ...... A cost-effectiveness analysis.
@ast
Latanoprost versus timolol as ...... A cost-effectiveness analysis.
@en
type
label
Latanoprost versus timolol as ...... A cost-effectiveness analysis.
@ast
Latanoprost versus timolol as ...... A cost-effectiveness analysis.
@en
prefLabel
Latanoprost versus timolol as ...... A cost-effectiveness analysis.
@ast
Latanoprost versus timolol as ...... A cost-effectiveness analysis.
@en
P2093
P2860
P1433
P1476
Latanoprost versus timolol as ...... A cost-effectiveness analysis.
@en
P2093
Andrea Peeters
Carroll A B Webers
Fred Hendrikse
Johan L Severens
Martin H Prins
P2860
P304
P356
10.1111/J.1755-3768.2009.01857.X
P577
2010-08-20T00:00:00Z